In vitro and in vivo models for the study of oral delivery of nanoparticles.

Adv Drug Deliv Rev

Department of Biomedical Engineering, Duke University, 101 Science Drive, Durham, NC 27708, USA.

Published: June 2013

Oral delivery is an attractive route to deliver therapeutics via nanoparticles due to its ease of administration and patient compliance. This review discusses laboratory techniques for studying oral delivery of nanoparticles, which offer protection of cargo through the gastrointestinal tract. Some of the difficulties in modeling oral delivery include the harsh acidic environment, variable pH, and the tight monolayer of endothelial cells present throughout the gastrointestinal tract. The use of in vitro techniques including the Transwell ® system, simulated gastric/intestinal fluid, and diffusion chambers addresses these challenges. When studying effects after oral delivery in vivo, bioimaging of nanoparticle biodistribution using radioactive markers has been popular. Functional assays such as immune response and systemic protein concentration analysis can further define the merits of the oral delivery systems. As biologics become increasingly more important in chronic therapies, nanoparticle-mediated oral delivery will assume greater prominence, and more sophisticated in vitro and in vivo models will be required.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773489PMC
http://dx.doi.org/10.1016/j.addr.2013.01.003DOI Listing

Publication Analysis

Top Keywords

oral delivery
28
vitro vivo
8
vivo models
8
delivery nanoparticles
8
gastrointestinal tract
8
oral
7
delivery
7
models study
4
study oral
4
nanoparticles oral
4

Similar Publications

Objectives: Primary care lacks emphasis on oral health (OH) despite its major effects on one's overall health. This mixed-methods bibliometric study was conducted to assess the content of OH in primary care journals.

Methods: Sixty-seven of the most influential journals were identified from primary care specialties and disciplines using Scopus CiteScore metrics and expert opinion.

View Article and Find Full Text PDF

Flurbiprofen (FBP) is poorly water-soluble BCS class II drug with anti-inflammatory and analgesic effects, used to treat arthritis and degenerative joint diseases. This study was aimed to develop SNEDDS loaded with FBP. Six SNEDDS using two oils olive oil (F, F, F) and castor oil (F, F, F) with three different Smix ratios consisting of Tween 20 and PEG 400 (1:1, 1:2, 2:1) were prepared and characterized.

View Article and Find Full Text PDF

Oral delivery of dihydroartemisinin for the treatment of melanoma via bovine milk exosomes.

Drug Deliv Transl Res

January 2025

Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi, 221005, Uttar Pradesh, India.

Cancer, particularly skin cancer, is a major cause of mortality worldwide, with melanoma being one of the most aggressive and challenging to treat types. Current therapeutic options, such as dacarbazine (DTIC), have limitations due to dose-related toxicities like liver toxicity. Therefore, there is a need for new and effective treatments for melanoma.

View Article and Find Full Text PDF

Oral delivery of MOMIPP lipid nanoparticles for methuosis-induced cancer chemotherapy.

Nanoscale

January 2025

School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.

Methuosis, a non-apoptotic pattern of cell death, triggers the accumulation of macropinosome-derived vacuoles in the cytoplasm. Through this novel mechanism, methuosis inducers possess great potential in fighting apoptosis-resistant cancer cells and offer a promising alternative for cancer treatment. However, the potent methuosis inducer, 3-(5-methoxy, 2-methyl-1-indol-3-yl)-1-(4-pyridinyl)-2-propen-1-one (MOMIPP), faces an intractable issue of insolubility in most solvents, hindering dosing and compromising the validation of its antitumor efficacy.

View Article and Find Full Text PDF

Perspectives of Yukon's frontline health care workers during the COVID-19 pandemic.

Int J Circumpolar Health

December 2025

Yukon Strategy for Patient-Oriented Research (YSPOR), Whitehorse, Yukon, Canada.

The perspectives of Yukon's nurses and physicians can determine what might mitigate burnout and strengthen the response to the COVID-19 pandemic and/or future health emergencies. The study was conducted in the Yukon Territory, Canada in two phases: completion of the Copenhagen Burnout Inventory (CBI), and in-depth oral interviews. This paper will discuss the results of the interviews.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!